HSBC Share Shop X

This link will allow you to access a non-HSBC website.

HSBC Group has no control over the linked website and is not liable for the use of it.

Continue

GlaxoSmithKline (GSK)
Share Price: 1,683.40p
Change Today:  8.40p  
Market Cap: 83,980m

Company Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Detailed Price Data

Share Price 1,683.40p Price Up Close 1,675.00p
Change Today +8.40p Volume 2,771,657
Percent Change +0.50% Day High / Low 1,697.16p / 1,675.00p
Update Time 14:10:35 Year High / Low 1,745.20p / 1,418.00p
Bid 1,683.40p Last Trade Price 1,683.40p
Offer 1,683.80p Last Trade Amount 643
Open 1,677.40p Last Trade Time 14:10:32

Income & Efficiency

Latest
Div Yield 4.8%
Div Cover 1.5
Op Mrgn 17.8%
ROCE 64.2%

Valuation

Latest
P/E 14.0
PEG 2.1
Pr/Revenue 2.7
Pr/Book 22.8

Growth

Latest
Revenue 2.1%
PBT 36.2%
EPS 6.8%
DPS n/a

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ShareCast News

Tuesday broker round-up 03-Sep-2019 12:59:45
Monday broker round-up 02-Sep-2019 13:16:34
GlaxoSmithKline reveals positive results from be... 23-Aug-2019 07:29:57

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 
This is a solution provided by Digital Look Corporate Solutions incorporating their prices, data, news, charts, fundamentals and investor tools on this site. Terms & Conditions